Back to search

Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US

Data up to Jan 2025

Published2005
Citations194
References95

Total Citations Per Year

Abstract

References (95)

Methods for the Economic Evaluation of Health Care Programmes

2005 • 11,095 citations

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1999 • 8,737 citations

Cost-Effectiveness in Health and Medicine

1996 • 6,853 citations

Cancer Statistics, 2005

2005 • 5,487 citations

Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers

2000 • 3,004 citations

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 • 1,624 citations

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

2002 • 1,570 citations

2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities

2002 • 1,232 citations

The Pap Test and Bethesda 2014

2015 • 1,122 citations

Epidemiology of Genital Human Papillomavirus Infection

1997 • 1,122 citations

Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities

2000 • 1,089 citations

Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data

2002 • 907 citations

The Hidden Epidemic

1997 • 749 citations

EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION

1988 • 700 citations

Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United States

1999 • 591 citations

Identifying Women With Cervical Neoplasia

1999 • 586 citations

Interim Guidelines for Management of Abnormal Cervical Cytology

1994 • 542 citations

The Relation between Funding by the National Institutes of Health and the Burden of Disease

1999 • 493 citations

Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical Abnormalities

2002 • 453 citations

The Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000

2004 • 431 citations

Task Force on Recurrent Respiratory Papillomas: A Preliminary Report

1995 • 422 citations

Using the World Health Organization Health and Work Performance Questionnaire (HPQ) to Evaluate the Indirect Workplace Costs of Illness

2004 • 415 citations

Quality of Care

1994 • 412 citations

Concordance of Self-reported Data and Medical Record Audit for Six Cancer Screening Procedures

1993 • 412 citations

Cancer and infection: estimates of the attributable fraction in 1990.

1997 • 394 citations

Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop

1994 • 357 citations

External Genital Warts: Diagnosis, Treatment, and Prevention

2002 • 355 citations

The Medical Expenditure Panel Survey: a national health information resource.

1996 • 335 citations

Cost Effectiveness of a Potential Vaccine forHuman papillomavirus

2003 • 321 citations

2001 Consensus Guidelines for the management of women with cervical intraepithelial neoplasia

2003 • 302 citations

Human Papillomavirus and head and neck cancer: Epidemiology and molecular biology

1998 • 302 citations

Recurrent Respiratory Papillomatosis: A Longitudinal Study Comparing Severity Associated With Human Papilloma Viral Types 6 and 11 and Other Risk Factors in a Large Pediatric Population

2004 • 288 citations

Diagnoses and outcomes in cervical cancer screening: A population-based study

2004 • 254 citations

Cancer prevention and control.

1990 • 226 citations

The Health and Economic Burden of Genital Warts in a Set of Private Health Plans in the United States

2003 • 223 citations

Accuracy of Self-Reported Health Services Use and Patterns of Care Among Urban Older Adults

1999 • 211 citations

2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities

2002 • 200 citations

Cervical biopsy-cytology correlation. A College of American Pathologists Q-Probes study of 22 439 correlations in 348 laboratories.

1996 • 191 citations

Accuracy of Self-Report of Mammography and Pap Smear in a Low-Income Urban Population

1998 • 191 citations

Annual cost of bipolar disorder to UK society

2002 • 190 citations

Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.

2001 • 181 citations

An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle

1998 • 174 citations

The frequency of Pap smear screening in the United States

2004 • 173 citations

Condyloma Acuminatum in Rochester, Minn, 1950-1978

1984 • 165 citations

Atypical squamous cells of undetermined significance: Interlaboratory comparison and quality assurance monitors

1994 • 160 citations

The psychosocial impact of human papillomavirus infection: implications for health care providers

1996 • 148 citations

Incidence and Prevalence of Recurrent Respiratory Papillomatosis among Children in Atlanta and Seattle

2000 • 146 citations

Cost Effectiveness of Cervical Cancer Screening for the Elderly

1992 • 143 citations

The health care costs of cervical human papillomavirus–related disease

2004 • 138 citations

Adult Respiratory Papillomatosis: Human Papillomavirus Type and Viral Coinfections as Predictors of Prognosis

1995 • 133 citations

Quality management in gynecologic cytology using interlaboratory comparison.

2000 • 118 citations

Correlates of underutilization of gynecological cancer screening among lesbian and heterosexual women

2003 • 114 citations

Where Do People Go for Treatment of Sexually Transmitted Diseases?

1999 • 114 citations

Quality Management in Gynecologic Cytology Using Interlaboratory Comparison

2000 • 113 citations

Genital Warts and Their Treatment

1999 • 112 citations

The Costs, Clinical Benefits, and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women

1999 • 108 citations

Pediatric Respiratory Papillomatosis: Prognostic Role of Viral Typing and Cofactors

1997 • 105 citations

Costs of Illness in Cost-Effectiveness Analysis

1994 • 104 citations

The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss

2001 • 100 citations

Is HIV infection a cofactor for cervical squamous cell neoplasia?

1999 • 98 citations

Genital Human Papillomavirus Infection

1987 • 95 citations

The Cost of Juvenile-Onset Recurrent Respiratory Papillomatosis

2000 • 89 citations

The Economic Burden of Cancer

1998 • 81 citations

The Economic Cost of Squamous Cell Cancer of the Head and Neck

2004 • 80 citations

PAPNET-Assisted Rescreening of Cervical Smears

1998 • 77 citations

Accuracy of patients' recall of Pap and cholesterol screening

2000 • 77 citations

The Measurement of Indirect Costs in the Health Economics Evaluation Literature:A Review

1998 • 76 citations

Patients Attending STD Clinics in an Evolving Health Care Environment

1997 • 75 citations

Cigarette Smoking, Oncogenic Human Papillomavirus, Ki-67 Antigen, and Cervical Intraepithelial Neoplasia

2004 • 75 citations

Are adolescents accurate in self-report of frequencies of sexually transmitted diseases and pregnancies?

1997 • 73 citations

Predictors of compliance with recommended cervical cancer screening schedule: a population-based study.

1999 • 69 citations

Distress after an abnormal Pap smear result: scale development and psychometric validation

2004 • 66 citations

Condylomata Acuminata (Genital Warts)

2001 • 65 citations

Risk factors for injury among construction workers at Denver International Airport

1998 • 64 citations

Public or Private Providers? U.S. Women's Use of Reproductive Health Services

2001 • 64 citations

Current cervical neoplasia screening practices of obstetrician/gynecologists in the US

2005 • 60 citations

Projection of the Future Dimensions and Costs of the Genital Herpes Simplex Type 2 Epidemic in the United States

2002 • 57 citations

TIME COSTS ASSOCIATED WITH CERVICAL CANCER SCREENING

2001 • 56 citations

Rescreening in gynecologic cytology. Rescreening of 3762 previous cases for current high-grade squamous intraepithelial lesions and carcinoma--a College of American Pathologists Q-Probes study of 312 institutions.

1995 • 53 citations

Pap Screening in a U.S. Health Plan

2004 • 53 citations

Impact of the bethesda system

1995 • 52 citations

Preventing Emerging Infectious Diseases: A Strategy for the 21st Century: Overview of the Updated CDC Plan

1998 • 49 citations

Progress in prophylactic and therapeutic vaccines for human papillomavirus infection

2003 • 49 citations

Cost-Effectiveness Analysis of Diagnosis and Management of Cervical Squamous Intraepithelial Lesions

1998 • 49 citations

Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S.

2000 • 45 citations

Determining Costs of Health Care Services for Cost-Effectiveness Analyses

1999 • 43 citations

The economic burden of gynecologic cancers in California, 1998

2003 • 39 citations

Burden of Migraine in Brazil: Estimate of Cost of Migraine to the Public Health System and an Analytical Study of the Cost‐Effectiveness of a Stratified Model of Care

2003 • 38 citations

The effect of additional shots on the vaccine administration process: results of a time-motion study in 2 settings.

2000 • 37 citations

Comparing Claims Data and Self-Reported Data with the Medical Record for Pap Smear Rates

1997 • 37 citations

Long-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance

1999 • 35 citations

The Value of Repeat Pap Smear at the Time of Initial Colposcopy

1997 • 28 citations

THE COST OF TREATING GENITAL WARTS

1996 • 27 citations

Validity of Self‐Reporting of Episodes of External Genital Warts

2002 • 23 citations

Adolescent HMO enrollees’ utilization of out-of-plan services

2001 • 17 citations

Cited By (0)

No citing papers found in database

Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human… (2005) – PharmacoEconomics | Metascience Observatory Explorer